In order to extend the scope of the CRA Code of Conduct to areas of the EthiFinance Group that collaborate with CRA activity, the code has been updated.
[...]EthiFinance Ratings is launching a request for comments for its new Debt Investment Funds Rating (DIF) methodology and is inviting market participants to submit their comments and suggestions. The Request for Comments period is starting on 22nd of July and is expected to last until 22nd of August. Unless specified [...]
EthiFinance Ratings, an independent European rating agency, has once again received the Analyst Forecast Awards from the economic analysis entity FocusEconomics, in the Fiscal Balance category for Spain, recognizing the company’s work for the fourth consecutive year and for the third time in this specific category. Specifically, the award recognizes [...]
Pharma Companies are now analysed using the General Corporate Rating Methodology. As of the 15th of July 2024, EthiFinance Ratings has decided to discontinue its Pharma Sector rating methodology. Pharma Companies are now analysed using the General Corporate Rating Methodology. Our decision is based on the fact that Pharma companies [...]
The General Corporate Methodology is only a merger of the three existing frameworks and our rating criteria remain unchanged. As of the 15th of July 2024, EthiFinance Ratings has decided to merge its Long-Term, Short-Term and Instruments Corporate Methodologies into a single General Corporate Methodology. Therefore, we are withdrawing the aforementioned three [...]
